Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s traded shares stood at 3.3 million during the last session, with the company’s beta value hitting 1.26. At the close of trading, the stock’s price was $2.44, to imply a decrease of -11.27% or -$0.31 in intraday trading. The ADPT share’s 52-week high remains $9.08, putting it -272.13% down since that peak but still an impressive -3.69% since price per share fell to its 52-week low of $2.53. The company has a valuation of $354.02M, with an average of 1.60 million shares over the past 3 months.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
After registering a -11.27% downside in the last session, Adaptive Biotechnologies Corp (ADPT) has traded red over the past five days. The stock hit a weekly high of 3.11, dropping -11.27% in its intraday price action. The 5-day price performance for the stock is -8.61%, and -23.27% over 30 days. With these gigs, the year-to-date price performance is -50.20%.
Adaptive Biotechnologies Corp (ADPT) estimates and forecasts
Looking at statistics comparing Adaptive Biotechnologies Corp share performance against respective industry, we note that the company has underperformed competitors. Adaptive Biotechnologies Corp (ADPT) shares are -44.04% down over the last 6 months, with its year-to-date growth rate lower than industry average at 5.07% against 12.80%. The rating firms project that company’s revenue will grow 3.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 7 analysts is $38.78 million. Meanwhile, for the quarter ending Jun 2024, a total of 7 analyst(s) estimate revenue growth to $43.36 million.Earnings reports from the last fiscal year show that sales brought in $37.65 million and -$ respectively in the corresponding quarters.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -32.91% for the past 5-year period. While 2024 is set for a 16.03% return in earnings, projections for the next 5 years are at 21.60% annually.
ADPT Dividends
Adaptive Biotechnologies Corp has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Adaptive Biotechnologies Corp has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
